Based on macroeconomic indicators such as economic growth, interest rates, exchange rates, and commodities, we conduct cross-asset flexible allocation to capture cyclical opportunities.
Deep industry research capabilities, focusing on core tracks including healthcare, AI, consumer, and logistics.
Continuous tracking of manager performance, risk control, and investment research systems, providing decision support for product screening and portfolio allocation.
Establishing a three-level risk control structure covering pre-investment due diligence, mid-investment monitoring, and post-investment tracking to safeguard long-term compound value.
Providing professional consulting services such as investment logic clarification, portfolio allocation suggestions, and risk assessment for institutions and enterprises.
Supporting investment decisions with objective and rigorous research, helping clients clarify market logic and optimize asset allocation.
Advised the client on the EUR 800 million cross-border acquisition, managing due diligence, valuation, negotiation, and closing processes.
Helped the enterprise secure nearly RMB 1 billion from strategic investors, accelerating its business expansion.
The roadshow showcased multi-strategy products and shared macro market insights, receiving widespread positive feedback from investors.
The report covers key information including product performance, portfolio structure analysis, and risk monitoring, ensuring transparent and timely post-investment disclosure.
Comprehensively updated investor risk classification standards and product matching rules, further enhancing the precision and standardization of client suitability management.
京公网安备 11010102004518号